Bioengineered In Situ-Forming Hydrogels as Smart Drug Delivery Systems for Postoperative Breast Cancer Immunotherapy: From Material Innovation to Clinical Translation
Source abstract
Abstract
Local recurrence after breast cancer surgery presents a critical challenge, demanding novel local immunotherapies capable of eliminating residual disease while avoiding systemic toxicity. In situ-forming hydrogels, functionalized with bioactive cargoes, represent a promising platform for precise spatiotemporal drug delivery directly into the post-resection tumor microenvironment. This review comprehensively examines the core design principles governing these advanced materials, highlighting their biocompatibility, stimuli-responsive behavior, tunable mechanics for conforming to surgical cavity, and capacity for multifunctional integration. A key mechanism discussed is how this controlled release profile orchestrates a temporal progression from innate immune activation to robust adaptive immunity. Despite significant promise, translational success faces substantial hurdles, including efficacy validation, scalable manufacturing, regulatory pathway definition, and the lack of predictive biomarkers. Future research priorities include optimizing drug/antigen release kinetics, establishing standardized characterization methods for complex biohybrid systems, and designing adaptive clinical trials incorporating detailed immunomonitoring. By integrating functional biomaterials with immuno-oncology, in situ-forming hydrogels offer a paradigm-shifting approach for postoperative cancer treatment. This review provides a strategic roadmap to accelerate their translation from bench to bedside.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau SAR, China
Funding
Macao Science and Technology Development Fund
References (100+)
Show source-provided references
1. Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies10.1007/s40265-013-0091-6 ↗
2. Bezu, L., Akal ksüz, D., Bell, M., Buggy, D., Diaz-Cambronero, O., Enlund, M., Forget, P., Gupta, A., Hollmann, M.W., and Ionescu, D. (2024). Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review. Cancers, 16.10.3390/cancers16132304 ↗
3. Combining surgery and immunotherapy: Turning an immunosuppressive effect into a therapeutic opportunity10.1186/s40425-018-0398-7 ↗
4. Cardiotoxicity of chemotherapy and targeted agents
5. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer10.1007/s10549-010-1132-4 ↗
6. Long-Term Cardiovascular Mortality After Radiotherapy for Breast Cancer10.1016/j.jacc.2010.08.638 ↗
7. Hu, Y., Zhu, Y., Qi, D., Tang, C., and Zhang, W. (2024). Trop2-targeted therapy in breast cancer. Biomark. Res., 12.10.1186/s40364-024-00633-6 ↗
8. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma in Situ10.1016/j.prro.2016.06.011 ↗
9. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy10.1126/sciadv.adc8738 ↗
10. Gel/hydrogel-based in situ biomaterial platforms for cancer postoperative treatment and recovery10.1002/EXP.20220173 ↗
11. Biomaterial-Based In Situ Cancer Vaccines10.1002/adma.202210452 ↗
12. Postsurgical wound management and prevention of triple-negative breast cancer recurrence with a pryoptosis-inducing, photopolymerizable hydrogel10.1016/j.jconrel.2023.02.042 ↗
13. An injectable hydrogel to modulate T cells for cancer immunotherapy10.1002/smll.202202663 ↗
14. Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors10.1126/sciadv.abn8264 ↗
15. Ziaei, A.A., Erfan-Niya, H., Fathi, M., and Amiryaghoubi, N. (2025). In situ fast gelling modified polyvinyl alcohol/polyethylene glycol hybrid hydrogels incorporating doxorubicin-loaded chitosan/AuNPs nanogels for localized treatment of breast cancer. Int. J. Biol. Macromol., 315.10.1016/j.ijbiomac.2025.144381 ↗
16. Wang, F., Su, H., Xu, D., Monroe, M.K., Anderson, C.F., Zhang, W., Oh, R., Wang, Z., Sun, X., and Wang, H. (2021). Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer. Biomaterials, 279.10.1016/j.biomaterials.2021.121182 ↗
17. Engineered Living Bacteriophage-Enabled Self-Adjuvanting Hydrogel for Remodeling Tumor Microenvironment and Cancer Therapy10.1021/acs.nanolett.2c04279 ↗
18. Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations10.1021/acsnano.3c01748 ↗
19. Designing spatial and temporal control of vaccine responses10.1038/s41578-021-00372-2 ↗
20. Zhong, Z., Gan, L., Feng, Z., Wang, W., Pan, X., Wu, C., and Huang, Y. (2024). Hydrogel local drug delivery systems for postsurgical management of tumors: Status Quo and perspectives. Mater. Today Bio, 29.10.1016/j.mtbio.2024.101308 ↗
21. Harnessing the potential of hydrogels for advanced therapeutic applications: Current achievements and future directions10.1038/s41392-024-01852-x ↗
22. Sustained-release hydrogel system for preventing postoperative tumor recurrence through synergistic immune signal enhancement for T cell activation10.1016/j.jcis.2025.138158 ↗
23. Unified Therapeutic--Prophylactic Vaccine Demonstrated with a Postoperative Filler Gel to Prevent Tumor Recurrence and Metastasis10.1002/adfm.202206084 ↗
24. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo10.1016/j.jconrel.2011.08.036 ↗
25. Injectable Hydrogels for Intratumoral Administration Against Breast Cancer10.1007/s10924-024-03344-z ↗
26. Jaiswal, C., Gupta, T., Jadi, P.K., Moses, J.C., and Mandal, B. (2022). Injectable anti-cancer drug loaded silk-based hydrogel for the prevention of cancer recurrence and post-lumpectomy tissue regeneration aiding triple-negative breast cancer therapy. Biomater. Adv., 145.10.1016/j.bioadv.2022.213224 ↗
27. Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy10.1016/j.addr.2022.114624 ↗
28. MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy10.2147/IJN.S432112 ↗
29. Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?10.21037/tau-23-563 ↗
30. Phase 2: A dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer10.1097/CAD.0b013e3283222c12 ↗
31. Attama, A.A., Nnamani, P.O., Onokala, O.B., Ugwu, A.A., and Onugwu, A.L. (2022). Nanogels as target drug delivery systems in cancer therapy: A review of the last decade. Front. Pharmacol., 13.10.3389/fphar.2022.874510 ↗
32. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption10.1016/j.carbpol.2023.121346 ↗
33. Hyaluronan: Molecular size-dependent signaling and biological functions in inflammation and cancer10.1111/febs.14777 ↗
34. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers in Vitro and in Vivo10.1021/acsami.7b06879 ↗
35. A comprehensive review on alginate-based delivery systems for the delivery of chemotherapeutic agent: Doxorubicin10.1016/j.carbpol.2021.117696 ↗
36. PLGA implants for controlled dexamethasone delivery: Impact of the polymer chemistry10.1016/j.jddst.2023.104648 ↗
37. Bakhrushina, E.O., Titova, S.A., Sakharova, P.S., Plakhotnaya, O.N., Grikh, V.V., Patalova, A.R., Gorbacheva, A.V., Krasnyuk, I.I., and Krasnyuk, I.I. (2025). Phase-Inversion In Situ Systems: Problems and Prospects of Biomedical Application. Pharmaceutics, 17.10.3390/pharmaceutics17060750 ↗
38. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products10.1016/j.jconrel.2022.09.031 ↗
39. Poly Ethylene Glycol (PEG)--Based Hydrogels for Drug Delivery in Cancer Therapy: A Comprehensive Review (Adv. Healthcare Mater. 18/2023)10.1002/adhm.202300105 ↗
40. Simultaneous cross-linking and cross-polymerization of enzyme responsive polyethylene glycol nanogels in confined aqueous droplets for reduction of low-density lipoprotein oxidation10.1021/acs.biomac.0c01238 ↗
41. A unified therapeutic–prophylactic tissue--engineering scaffold demonstrated to prevent tumor recurrence and overcoming infection toward bone remodeling10.1002/adma.202300313 ↗
42. Tanga, S., Aucamp, M., and Ramburrun, P. (2023). Injectable Thermoresponsive Hydrogels for Cancer Therapy: Challenges and Prospects. Gels, 9.10.3390/gels9050418 ↗
43. Design of carboxymethyl chitosan-reinforced pH-responsive hydrogels for on-demand release of carvacrol and simulation of release kinetics10.1016/j.foodchem.2022.134856 ↗
44. Preparation and performance of a stimuli-responsive drug delivery system: Novel light-triggered temperature-sensitive drug-loaded microcapsules10.1039/D3TB01836A ↗
45. Bioresponsive Hyaluronic Acid--Based Hydrogel Inhibits Matrix Metalloproteinase--2 in Glioblastoma Microenvironment10.1002/cmdc.202401040 ↗
46. Enhancing the ROS sensitivity of a responsive supramolecular hydrogel using peroxizyme catalysis10.1021/acs.biomac.3c00262 ↗
47. Ouyang, H., Xie, X., Xie, Y., Wu, D., Luo, X., Wu, J., Wang, Y., and Zhao, L. (2022). Compliant, tough, anti-fatigue, self-recovery, and biocompatible phema-based hydrogels for breast tissue replacement enabled by hydrogen bonding enhancement and suppressed phase separation. Gels, 8.10.3390/gels8090532 ↗
48. Promoting lacunar bone regeneration with an injectable hydrogel adaptive to the microenvironment
49. A Cohesive Shear-Thinning Biomaterial for Catheter-Based Minimally Invasive Therapeutics10.1021/acsami.2c08799 ↗
50. A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers10.1016/j.apsb.2025.04.020 ↗
51. Effect of peptide–polymer host–guest electrostatic interactions on self-assembling peptide hydrogels structural and mechanical properties and polymer diffusivity10.1021/acs.biomac.4c00232 ↗
52. Biocompatible composite hydrogel with on-demand swelling-shrinking properties for 4D bioprinting10.1039/D5BM00551E ↗
53. Zhong, Y., Yu, Y., Peng, Y., Su, Z., Mao, Y., Chen, Y., Wang, L., Xin, M., and Li, M. (2025). Construction of Schiff base dynamically cross-linked pH-responsive chitosan-based hydrogels and investigation of their targeted oral delivery performance for vitamin B12. Int. J. Biol. Macromol., 316.10.1016/j.ijbiomac.2025.144478 ↗
54. Gelatin/carboxymethyl cellulose based stimuli-responsive hydrogels for controlled delivery of 5-fluorouracil, development, in vitro characterization, in vivo safety and bioavailability evaluation10.1016/j.carbpol.2021.117617 ↗
55. Wu, F., Chen, H., Liu, J., and Pang, Y. (2025). Generating structurally and functionally programmable hydrogels by biological membrane hybridization. Nat. Protoc., 1–32.10.1038/s41596-025-01247-4 ↗
56. Tailoring hyaluronic acid hydrogels: Impact of cross-linker length and density on skin rejuvenation as injectable dermal fillers and their potential effects on the MAPK signaling pathway suppression
57. Silk-based hydrogel incorporated with metal-organic framework nanozymes for enhanced osteochondral regeneration
58. Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing10.1038/s41467-024-50072-y ↗
59. Bu, W., Wu, Y., Ghaemmaghami, A.M., Sun, H., and Mata, A. (2022). Rational design of hydrogels for immunomodulation. Regen. Biomater., 9.10.1093/rb/rbac009 ↗
60. Byun, J., Wu, Y., Lee, J., Kim, J.S., Shim, G., and Oh, Y.-K. (2023). External cold atmospheric plasma-responsive on-site hydrogel for remodeling tumor immune microenvironment. Biomaterials, 299.10.1016/j.biomaterials.2023.122162 ↗
61. Dynamic mechanical analysis of alginate/gellan hydrogels under controlled conditions relevant to environmentally sensitive applications10.1016/j.carbpol.2024.123180 ↗
62. An Integrally Formed Janus Hydrogel for Robust Wet-Tissue Adhesive and Anti-Postoperative Adhesion10.1002/adma.202300394 ↗
63. Progress in chitin/chitosan and their derivatives for biomedical applications: Where we stand10.1016/j.carbpol.2024.122233 ↗
64. Mussel-inspired chitosan and its applications in the biomedical field10.1016/j.carbpol.2024.122388 ↗
65. Instantaneous Self--Healing Chitosan Hydrogels with Enhanced Drug Leakage Resistance for Infected Stretchable Wounds Healing10.1002/smll.202409641 ↗
66. Nano Sim@ ZIF8@ PDA modified injectable temperature sensitive nanocomposite hydrogel for photothermal/drug therapy for peri-implantitis10.1016/j.carbpol.2025.123327 ↗
67. Multi-responsive chitosan-based hydrogels for controlled release of vincristine10.1038/s42004-023-00829-1 ↗
68. Engineered in-situ-forming biomimetic hydrogel with self-regulated immunostimulatory capacity promotes postoperative tumor treatment10.1016/j.fmre.2023.02.029 ↗
69. pH-responsive nanocomposite hydrogel for simultaneous prevention of postoperative adhesion and tumor recurrence10.1016/j.actbio.2022.12.025 ↗
70. Effect of cell adhesiveness of Cell Dome shell on enclosed HeLa cells10.1016/j.jbiosc.2024.01.002 ↗
71. A biomimetic multi-component subunit vaccine via ratiometric loading of hierarchical hydrogels10.1038/s41467-025-60416-x ↗
72. An Injectable Chitosan Hydrochloride-Sodium Alginate Hydrogel Adjuvant Capable of Eliciting Potent Humoral and Cellular Immunity10.1021/acsami.4c15189 ↗
73. Chemical cross--linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual--antigen subunit vaccine10.1002/mco2.70045 ↗
74. Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors10.1038/s41467-023-39330-7 ↗
75. Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy10.1016/j.jconrel.2023.05.005 ↗
76. Immune-modulative nano-gel-nano system for patient-favorable cancer therapy
77. A laponite-based immunologically active gel delivery system for long-acting tumor vaccine10.1016/j.jconrel.2024.07.030 ↗
78. Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy10.1021/acsnano.3c12337 ↗
79. Mapping in vivo microclimate pH distribution in exenatide-encapsulated PLGA microspheres10.1016/j.jconrel.2022.08.043 ↗
80. Wang, X., Sun, H., Song, M., Yan, G., and Wang, Q. (2022). The Biodegradability and in Vitro Cytological Study on the Composite of PLGA Combined with Magnesium Metal. Front. Bioeng. Biotechnol., 10.10.3389/fbioe.2022.859280 ↗
81. Self-Amplified Cascade Degradation and Oxidative Stress Via Rational pH Regulation of Oxidation-Responsive Poly(ferrocene) Aggregates10.1021/jacs.3c04454 ↗
82. Immunomodulatory Biomaterials: Tailoring Surface Properties to Mitigate Foreign Body Reaction and Enhance Tissue Regeneration10.1002/adhm.202401253 ↗
83. Iota carrageenan gold-silver NPs photothermal hydrogel for tumor postsurgical anti-recurrence and wound healing10.1016/j.carbpol.2022.120123 ↗
84. Tuning chitosan’s chemical structure for enhanced biological functions10.1016/j.tibtech.2022.11.009 ↗
85. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence10.1016/j.actbio.2021.10.039 ↗
86. Reversal of postoperative breast cancer metastasis by the use of embedded hydrogel10.62347/VZAW2270 ↗
87. pH-Sensitive hydrogels for breast cancer therapy: Targeted drug delivery and controlled release approaches10.1016/j.ijpharm.2025.125899 ↗
88. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis10.1016/j.actbio.2024.01.037 ↗
89. Goodarzi, K., and Rao, S.S. (2024). Structurally decoupled hyaluronic acid hydrogels for studying matrix metalloproteinase-mediated invasion of metastatic breast cancer cells. Int. J. Biol. Macromol. Struct. Funct. Interact., 277.10.1016/j.ijbiomac.2024.134493 ↗
90. Combination of biodegradable hydrogel and antioxidant bioadhesive for treatment of breast cancer recurrence and radiation skin injury
91. Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment10.2147/IJN.S492713 ↗
92. Zhang, B., Li, M., Ji, J., Si, X., Yin, X., Ji, G., Ren, L., and Yao, H. (2025). A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy. Front. Immunol., 16.10.3389/fimmu.2025.1523436 ↗
93. Enhanced human T cell expansion with inverse opal hydrogels10.1039/D2BM00486K ↗
94. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-110.1016/j.actbio.2024.04.025 ↗
95. Integration of Melt Electrowritten Polymeric Scaffolds and Bioprinting for Epithelial Healing via Localized Periostin Delivery10.1021/acsmacrolett.4c00240 ↗
96. Programmable hierarchical hydrogel dressing for sequential release of growth factor and DNase to accelerate diabetic wound healing10.1016/j.jconrel.2025.113825 ↗
97. Dynamic Hybrid Module-Driven NK Cell Stimulation and Release for Tumor Immunotherapy10.1021/acs.nanolett.4c00425 ↗
98. PEI-Based Nanoparticles for Tumor Immunotherapy via In Situ Antigen-Capture Triggered by Photothermal Therapy10.1021/acsami.3c13405 ↗
99. A cell-laden hydrogel as prophylactic vaccine and anti-PD-L1 amplifier against autologous tumors10.1016/j.jconrel.2022.09.027 ↗
100. Engineered Bio--Based Hydrogels for Cancer Immunotherapy10.1002/adma.202313188 ↗